GlobeNewswire Inc.··NaDyne Therapeutics Launches Phase 3 Trial for Z-Basivarsen in Myotonic Dystrophy
Dyne Therapeutics initiates Phase 3 HARMONIA trial testing z-basivarsen in approximately 150 DM1 patients, aiming to convert accelerated approval to traditional FDA clearance.
DYNPhase 3 clinical trialFDA approval